lino Biotech exhibits its products at the DxPx conference
ZURICH – (COMMERCIAL THREAD) – lino Biotech AG, the only company in the world specializing in focal molography – an entirely new method for measuring molecular interactions in living cells or raw biological samples – is part of the DxPx conference as a silver sponsor and will present its new products. The company supports the Conference, among other sponsors such as the gold sponsor Roche and the silver sponsors Hologic and synevo. The program of the DxPx conference on November 16e 2021 at the Maritim Hotel in DÃ¼sseldorf, Germany with the expansion of the digital partnership option from November 12e – 20e 2021, includes several round tables, as well as fireside discussions with renowned speakers. lino Biotech will also present its products among other startups and growing companies at the accompanying exhibition.
As a sponsor of the annual flagship conference, lino Biotech offers any investor interested in meeting him a free gift for the event. “With our sponsorship, we want to promote an intensive dialogue between newcomers to the industry, established businesses and investors, because we know how difficult it can be for small businesses to gain attention,” says Dr Volker Gat Rotterdam, Vice President Commercial at lino Biotech. .
The company will showcase its biosensor platform and new performance data at the Industry & Investor Partnering Conference in Diagnostics, Digital Health, Precision Medicine, and Life Science Tools on November 16.e on site in DÃ¼sseldorf. Investors interested in meeting the company can contact lino Biotech to obtain tickets to access the conference.
About lino Biotech AG:
lino Biotech AG – www.lino-biotech.com – was incorporated as a spin-out of ETH Zurich in Zurich, Switzerland, in March 2020, and is supported by Roche Venture Fund, High-Tech GrÃ¼nderfonds and several life science family offices. lino Biotech is a tool company for the life sciences, offering biosensors and readers for the analysis of complex solutions. The brand new method of measuring molecular interactions enables cell and gene therapy customers to optimize their R&D and production processes, reduce costs and improve product quality. In the future, technological lino molography will also offer new applications in bioprocesses, diagnostics and precision medicine.